International: Page 9

Japan to Consider Medical Cannabis Legislation

A Japanese health ministry panel suggested adapting the country’s cannabis laws to meet medical needs and evolving international standards.

Cookies Signs Deal With Portugal-Based Akanda Corp.

The licensing agreement will see Cookies genetics land in European cannabis markets for the first time.

Australian Government Could Override State Laws to Legalize Adult-Use Cannabis

The Greens received new constitutional advice on the issue as the minor party ramps up its legalization campaign.

SOMAÍ Pharmaceuticals Opens Portugal Manufacturing Facility

SOMAÍ’s phase 1 manufacturing footprint spans 3,800 square meters of manufacturing floor, independent laboratory and offices.

Flora Growth Completes Multiple Commercial Cannabis Exports Into New International Markets

The company also completed its first commercial export of CBD isolate to the United States.

Cannabis Remains Banned by World Anti-Doping Agency

The agency’s executive committee included cannabis on its 2023 list of prohibited substances during a Sept. 23 meeting.

Tilray Medical Receives Approval to Extend Market Authorization in Italy

The Italian Ministry of Health has approved Tilray-branded medical cannabis for pharmaceutical distribution.

New Zealand Approves First Locally Grown Medical Cannabis Products

Helius Therapeutics becomes the first Kiwi company to receive approval to source products from locally grown cannabis.

Curaleaf Completes Majority Stake Acquisition of Germany’s Four 20 Pharma

The deal solidifies Curaleaf’s strategic advantage in Germany as the country prepares for adult use.

Akanda Partners with Cookies to Bring the Cannabis Brand and High THC Strains to European Consumers

The exclusive licensing agreement enables Akanda to cultivate, manufacture and sell Cookies branded products in Portugal, including operating Cookies branded pharmacy outlets.

Merida Capital Holdings Partners With Azucarera El Viejo for Medical Cannabis Facility in Costa Rica

The partnership comes after the Central American country legalized the use of cannabis for medical and therapeutic purposes.

BDSA Reports Global Cannabis Sales Will Grow 10% in 2022; Forecasts $57 Billion Market by 2026

Despite an inflationary environment, U.S. cannabis sales are expected to reach $27 billion by the end of 2022, a jump of 7% over 2021 sales.

Previous Page

Page 9 of 64

Next Page